临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2015年
12期
9-10
,共2页
卒中%抑郁%尼莫地平%治疗结果
卒中%抑鬱%尼莫地平%治療結果
졸중%억욱%니막지평%치료결과
Stroke%Depression%Nimodipine%Treatment outcome
目的:探讨早期应用尼莫地平治疗脑卒中后抑郁症的临床疗效。方法选取闻喜县薛店镇卫生院2011年2月—2013年7月收治的156例脑卒中后抑郁症患者,随机分为观察组和对照组,每组78例。对照组采用常规神经内科治疗,观察组患者在对照组基础上早期应用尼莫地平治疗,疗程为4周。治疗结束后,比较两组患者的抗抑郁效果、日常生活能力(ADL)评分以及神经功能改善情况。结果观察组患者的抗抑郁总有效率、ADL 评分以及神经功能治疗总有效率均高于对照组,差异有统计学意义( P <0.05)。结论早期应用尼莫地平治疗脑卒中后抑郁症可较快改善患者缺损的神经功能,改善抑郁症状,提高治疗效果。
目的:探討早期應用尼莫地平治療腦卒中後抑鬱癥的臨床療效。方法選取聞喜縣薛店鎮衛生院2011年2月—2013年7月收治的156例腦卒中後抑鬱癥患者,隨機分為觀察組和對照組,每組78例。對照組採用常規神經內科治療,觀察組患者在對照組基礎上早期應用尼莫地平治療,療程為4週。治療結束後,比較兩組患者的抗抑鬱效果、日常生活能力(ADL)評分以及神經功能改善情況。結果觀察組患者的抗抑鬱總有效率、ADL 評分以及神經功能治療總有效率均高于對照組,差異有統計學意義( P <0.05)。結論早期應用尼莫地平治療腦卒中後抑鬱癥可較快改善患者缺損的神經功能,改善抑鬱癥狀,提高治療效果。
목적:탐토조기응용니막지평치료뇌졸중후억욱증적림상료효。방법선취문희현설점진위생원2011년2월—2013년7월수치적156례뇌졸중후억욱증환자,수궤분위관찰조화대조조,매조78례。대조조채용상규신경내과치료,관찰조환자재대조조기출상조기응용니막지평치료,료정위4주。치료결속후,비교량조환자적항억욱효과、일상생활능력(ADL)평분이급신경공능개선정황。결과관찰조환자적항억욱총유효솔、ADL 평분이급신경공능치료총유효솔균고우대조조,차이유통계학의의( P <0.05)。결론조기응용니막지평치료뇌졸중후억욱증가교쾌개선환자결손적신경공능,개선억욱증상,제고치료효과。
Objective To study the clinical efficacy of nimodipine in the treatment of post - stroke depression in early stage. Methods In Xuedian Health Center of Wenxi County from February 2011 to July 2013 156 post - stroke depression pait-ients were selected,they were randomly divided into observation group and control group,78 cases in each group. Control group were treated with conventional medical treatment,observation group were treated with early application of nimodipine treat-ment on the basis of control group,both groups treated for four weeks. After treatment,antidepressant effect,activities of daily living(ADL)scores and neurological function between the two groups were compared. Results Antidepressant total effective rate,ADL scores and neurological function total effective rate of observation group were higher than control group,the differ-ences wre statistically significant(P < 0. 05). Conclusion Nimodipine can quickly improve neurological defects,improve de-pressive symptomsin the treatment of post - stroke depression in early stage.